Dr. Anthony D Elias, M.D.
Claim this profileUniversity of Colorado
Studies Breast Cancer
Studies Cancer
12 reported clinical trials
32 drugs studied
Area of expertise
1Breast Cancer
Stage IV
Stage III
ER positive
2Cancer
Stage IV
Stage III
ER positive
Affiliated Hospitals
Clinical Trials Anthony D Elias, M.D. is currently running
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
More about Anthony D Elias, M.D.
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Anthony D Elias, M.D. has experience with
- Paclitaxel
- CAB-ROR2-ADC
- PD-1 Inhibitor
- Fulvestrant
- Enzalutamide
- Atezolizumab
Breakdown of trials Anthony D Elias, M.D. has run
Breast Cancer
Cancer
Tumors
Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anthony D Elias, M.D. specialize in?
Anthony D Elias, M.D. focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Anthony D Elias, M.D. currently recruiting for clinical trials?
Yes, Anthony D Elias, M.D. is currently recruiting for 3 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Anthony D Elias, M.D. has studied deeply?
Yes, Anthony D Elias, M.D. has studied treatments such as Paclitaxel, CAB-ROR2-ADC, PD-1 inhibitor.
What is the best way to schedule an appointment with Anthony D Elias, M.D.?
Apply for one of the trials that Anthony D Elias, M.D. is conducting.
What is the office address of Anthony D Elias, M.D.?
The office of Anthony D Elias, M.D. is located at: University of Colorado, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.